Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - Moleculin Biotech, Inc. | ex_205814.htm |
| EX-32.1 - EXHIBIT 32.1 - Moleculin Biotech, Inc. | ex_205816.htm |
| EX-4.10 - EXHIBIT 4.10 - Moleculin Biotech, Inc. | ex_235706.htm |
| EX-31.2 - EXHIBIT 31.2 - Moleculin Biotech, Inc. | ex_205815.htm |
| EX-32.2 - EXHIBIT 32.2 - Moleculin Biotech, Inc. | ex_205817.htm |
| EX-10.23 - EXHIBIT 10.23 - Moleculin Biotech, Inc. | ex_235841.htm |
| 10-K - FORM 10-K - Moleculin Biotech, Inc. | mbrx20201231_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We have issued our report dated March 24, 2021, with respect to the consolidated financial statements included in the Annual Report of Moleculin Biotech, Inc. on Form10-K for the year ended December 31, 2020. We consent to the incorporation by reference of said reports in the Registration Statements of Moleculin Biotech, Inc. on Forms S-1 (File No. 333-214898, File No. 333-215974, File No. 333-224243, File No. 333-226146 and File No. 333-227845), Form S-3 (File No. 333-219434, File No. 333-252676 and File No. 333-235686) and on Forms S-8 (File No. 333-212619, File No. 333-225867, and File No. 333-248240).
/s/ GRANT THORNTON LLP
Houston, Texas
March 24, 2021